Resveratrol and p53 in Colorectal Cancer
Author Information
Author(s): Brockmueller Aranka, Buhrmann Constanze, Moravejolahkami Amir Reza, Shakibaei Mehdi
Primary Institution: Ludwig-Maximilians-University Munich
Hypothesis
Does resveratrol modulate the p53 signaling pathway to inhibit cancer cell plasticity and promote apoptosis in colorectal cancer cells?
Conclusion
Resveratrol effectively modulates p53 signaling, reducing cancer cell plasticity and promoting apoptosis in colorectal cancer.
Supporting Evidence
- Resveratrol reduces cell plasticity and promotes apoptosis in colorectal cancer cells.
- p53 is a key regulator in preventing cancer cell survival and promoting cell death.
- Resveratrol's effects are linked to its ability to modulate inflammatory pathways.
Takeaway
Resveratrol is a natural compound that helps fight colon cancer by making cancer cells less flexible and more likely to die.
Methodology
This review summarizes existing research on the effects of resveratrol on colorectal cancer, focusing on its interaction with the p53 pathway.
Limitations
The review primarily discusses in vitro and in vivo studies, with limited clinical trial data available.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website